Description
Description
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) peptide primarily used to reduce visceral (belly) fat in HIV patients with lipodystrophy. It offers significant metabolic benefits, including improved lipid profiles, reduced visceral adipose tissue (VAT), increased lean muscle mass, improved insulin sensitivity, and enhanced energy/sleep quality.
Composition
- Tesamorelin: 10 mg
- Appearance: lyophilized powder in a sealed research vial
Research Focus (non-clinical)
- Identity and purity assessment
- Chromatographic method optimization for variant/impurity profiling
- Stability characterization of a lyophilized peptide under laboratory storage conditions
Documentation
- Lot-specific COA available
- Batch and lot traceability
Important Notice
- For research use only
- Not for human consumption
- Not intended to diagnose, treat, cure, or prevent any disease
Quality & Manufacturing
- Lot-specific COA
- Lyophilized for transit stability; batch traceable
- Tamper-evident seal; lot & test date on each vial
- No MOQ for online orders
- Bulk orders for physical locations start at 25-unit minimum
